Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) SVP Emily Dreyer sold 14,025 shares of Trupanion stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.41, for a total transaction of $454,550.25. Following the sale, the senior vice president now directly owns 27,645 shares in the company, valued at $895,974.45. The trade was a 33.66 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Trupanion Price Performance
Trupanion stock opened at $33.20 on Wednesday. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The company’s fifty day moving average price is $43.50 and its 200 day moving average price is $47.33. The stock has a market capitalization of $1.41 billion, a P/E ratio of -144.35, a P/E/G ratio of 6.02 and a beta of 1.70.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. As a group, equities research analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Institutional Trading of Trupanion
Wall Street Analyst Weigh In
Several brokerages have issued reports on TRUP. Stifel Nicolaus decreased their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Piper Sandler dropped their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.60.
View Our Latest Stock Report on Trupanion
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to Plot Fibonacci Price Inflection Levels
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.